Guerrini Susanna, Del Roscio Davide, Zanoni Matteo, Cameli Paolo, Bargagli Elena, Volterrani Luca, Mazzei Maria Antonietta, Luzzi Luca
Unit of Diagnostic Imaging, Department of Radiological Sciences, Azienda Ospedaliero-Universitaria Senese, University of Siena, 53100 Siena, Italy.
Unit of Diagnostic Imaging, Department of Medical, Surgical and Neuro Sciences and of Radiological Sciences, Azienda Ospedaliero-Universitaria Senese, University of Siena, 53100 Siena, Italy.
Int J Environ Res Public Health. 2022 Feb 21;19(4):2460. doi: 10.3390/ijerph19042460.
Lung cancer (LC) represents the main cause of cancer-related deaths worldwide, especially because the majority of patients present with an advanced stage of the disease at the time of diagnosis. This systematic review describes the evidence behind screening results and the current guidelines available to manage lung nodules. This review was guided by the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. The following electronic databases were searched: PubMed, EMBASE, and the Web of Science. Five studies were included in the systematic review. The study cohort included 46,364 patients, and, in this case series, LC was detected in 9028 patients. Among the patients with detected LC, 1261 died of lung cancer, 3153 died of other types of cancers and 4614 died of other causes. This systematic review validates the use of CT in LC screening follow-ups, and bids for future integration and implementation of nodule management protocols to improve LC screening, avoid missed cancers and to reduce the number of unnecessary investigations.
肺癌(LC)是全球癌症相关死亡的主要原因,特别是因为大多数患者在诊断时已处于疾病晚期。本系统评价描述了筛查结果背后的证据以及目前用于管理肺结节的指南。本评价遵循系统评价和Meta分析的首选报告项目(PRISMA)指南。检索了以下电子数据库:PubMed、EMBASE和科学网。五项研究纳入了本系统评价。研究队列包括46364名患者,在这个病例系列中,9028名患者被检测出患有肺癌。在检测出肺癌的患者中,1261人死于肺癌,3153人死于其他类型癌症,4614人死于其他原因。本系统评价验证了CT在肺癌筛查随访中的应用,并呼吁未来整合和实施结节管理方案,以改善肺癌筛查,避免漏诊癌症并减少不必要的检查数量。